Power to the Patients copertina

Power to the Patients

Power to the Patients

Di: Brandon Li
Ascolta gratuitamente

3 mesi a soli 0,99 €/mese

Dopo 3 mesi, 9,99 €/mese. Si applicano termini e condizioni.

A proposito di questo titolo

 Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com315762 Scienza Scienze biologiche
Episodi
  • The 20-Year Industry Secret: Redefining Neurodegenerative Treatment

    The 20-Year Industry Secret: Redefining Neurodegenerative Treatment
    Jan 9 2026
    In this episode of Power to the Patients, Brandon Li sits down with Dr. Gabriel Vargas, Chief Medical Officer at CuraSen Therapeutics, to explore how targeting the adrenergic system could offer both symptomatic relief and disease-modifying potential for Alzheimer's, Parkinson's, and depression. From his two decades developing breakthrough therapies in neurology and psychiatry, including the migraine treatment Erenumab, Dr. Vargas breaks down translational medicine, challenges the amyloid hypothesis, and reveals why shorter clinical trials may be missing the bigger picture.
    Mostra di più Mostra meno
    53 min
  • One Mechanism, Three Conditions: A New Direction in Neurological Treatment

    One Mechanism, Three Conditions: A New Direction in Neurological Treatment
    Dec 3 2025
    What if inflammation was the key to unlocking treatments for Alzheimer's, Parkinson's, and Long COVID? In this episode of Power to the Patients, Brandon Li sits down with Cuong Do, CEO of BioVie, to explore the fascinating intersection of these seemingly unrelated conditions. From diving into medical research at the age of 14 to leading groundbreaking clinical trials, Cuong shares invaluable insights on biotech innovation, trial design, and navigating today's challenging funding landscape. Tune in to discover how a single molecule's unique ability to cross the blood-brain barrier could potentially transform treatment for millions of patients.
    Mostra di più Mostra meno
    35 min
  • Why Traditional Psychedelics Miss 90% of Neurology Patients - And The Solution

    Why Traditional Psychedelics Miss 90% of Neurology Patients - And The Solution
    Nov 12 2025
    In this episode of Power to the Patients, Brandon Li sits down with Dr. Chris Witowski, CEO and Co-Founder of Psilera, to explore the fascinating intersection of psychedelics and neurodegeneration. Discover how non-hallucinogenic compounds could revolutionize treatments for conditions like frontotemporal dementia, why traditional psychedelics may have overlooked neurodegenerative applications, and the future of neuroplasticity-based therapies. From biomarker development to innovative drug delivery systems, this conversation offers deep insights into an emerging frontier in neuroscience that could transform patient care beyond traditional psychiatric applications.
    Mostra di più Mostra meno
    42 min
Ancora nessuna recensione